(2021). Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports. Reactions Weekly.
Chicago-стиль цитирования"Methylprednisolone/tocilizumab: Lack of Efficacy in Off-label Use: 7 Case Reports." Reactions Weekly 2021.
MLA-цитирование"Methylprednisolone/tocilizumab: Lack of Efficacy in Off-label Use: 7 Case Reports." Reactions Weekly 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.